- Cures
If you do not have an existing account, you can register to access the State of California’s Prescription Drug Monitoring Program (CURES) by clicking Register for an Account
- CNBC Cures
We bring you insights about the biggest stories impacting the rare disease community and highlight the research being done that will change the way we think about modern medicine for everyone
- CNBC Cures - CNBC Events
Join us for the first annual CNBC Cures Summit, a landmark live event bringing together the most influential investors, policy makers and leaders in biotechnology to accelerate the future of medicine through breakthroughs in rare disease research
- Controlled Substance Utilization Review and Evaluation System
CURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, Schedule III, Schedule IV and Schedule V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement
- Legislation - ONC - Office of the National Coordinator for Health . . .
Explore key health IT legislation, including the Cures Act, HITECH, MACRA, and HIPAA, driving interoperability and improving care
- 21st Century Cures Act EHR Requirements: 2026 Integration Guide
Understand the 21st Century Cures Act EHR requirements, including API access, interoperability, and compliance strategies for 2026
- Cures - California
Register for California's Controlled Substance Utilization Review and Evaluation System (CURES) to access and manage controlled substance data securely
- CURES Regulations - Office of the Attorney General
The conditions under which a warrant, subpoena, or court order is required for a law enforcement agency to obtain information from CURES as part of a criminal investigation
|